The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so the only times I will typically switch somebody from a gabapentin if they're getting benefit is when they've maxed out the dose they're getting benefit but there's no point in giving them more i'll switch to pregablin where I can drive more into their system
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
again you're using these for the most recalcitrant neuropathic pain typically i'm using these for the most recalcitrant pain in general
So, the only times I will typically switch somebody from a gabapentin if they're getting benefit is when they've maxed out the dose. They're getting benefit, but there's no point in giving them more. I'll switch to pregablinin where I can drive more into their system.